News & Resources
Read our latest insights and explore our resources, including company updates, articles, white papers, case studies, webinars and more.
-
Navigating the Evolving Landscape of Decentralized Clinical Trials
Jonathan Ernst, Vice President of In-Home Solutions at PCM Trials, shared his insights on the evolving landscape of decentralized clinical trials (DCTs) in a recent interview. Ernst discussed the challenges, opportunities, and strategies involved in integrating DCT elements into modern clinical trials and how PCM Trials is pushing to expand […]
-
Infusion and Follow Up at Home for Alzheimer’s Global Home Visits Exceed Expectations in a Challenging Study
Background Alzheimer’s disease is an age-related neurodegenerative disorder charactered by progressive decline in cognitive function and the ability to perform activities of daily living, ultimately resulting in dementia with fatal complications. Evidence suggests that the pathophysiological process of Alzheimer’s begins well more than decade before the clinical stage now recognized […]
-
Blazing a New Path: An Innovative Approach to Screening Patients
Background The pathophysiological process of Alzheimer’s Disease begins more than a decade before Alzheimer’s Disease dementia. In this stage, individuals have preserved cognitive abilities but underlying Alzheimer’s Disease pathophysiology, known as preclinical Alzheimer’s Disease. Consensus in the field is that compounds targeting the underlying disease process may have greater benefit […]
-
How Mobile Nursing is Evolving to Meet Stringent Demands of Today’s Decentralized Clinical Trials
There was a time when decentralized clinical trial (DCT) methods were seen as an accommodation to be used only as a last resort, but that’s no longer the case. The dramatic rise in DCTs spurred by the pandemic continues today, to the point that every sponsor, CRO and site should […]
-
How Mobile Nursing is Evolving to Deliver Efficient Decentralized Clinical Trials
Ellen Weiss, PCM Trials’ vice president, in-home solutions, will help you understand how deploying a team of properly trained mobile research nurses can transform your remote trials, making them more efficient and more diverse, while improving participant retention. When participation in your trials is more convenient for patients, you’ll increase […]
-
Dr. Cummings at OCT East Coast Clinical Trials from Home
The renowned researcher interviewed by CheckRare about largest Parkinson’s study ever attempted. Dr. Steven Cummings highlights role of PCM Trials certified mobile research nurses in making possible large-scale home-based clinical trials.
-
Renowned researcher interviewed by CheckRare
The renowned researcher interviewed by CheckRare about the largest Parkinson’s study ever attempted. Dr. Steven Cummings highlights the role of PCM Trials certified mobile research nurses in making possible large-scale home-based clinical trials.
-
PCM Trials VP of In-Home Solutions Shares How Lessons Learned from the Pandemic Will Improve Clinical Trials Moving Forward
CenterWatch hosted a webinar featuring Ellen Weiss, vice president of in-home solutions for PCM Trials. As a leading provider of certified mobile research nurses to the clinical trials industry that has supported more than 300 protocols over 14 years and conducted more than 42,000 home visits, PCM Trials is in […]
-
DCT Planning Checklist:Your Guide to Ensuring a Successful Decentralized or Hybrid Trial
Executive Summary Even before the COVID-19 pandemic spotlighted the benefits of decentralized clinical trials (DCTs), their use was becoming more commonplace. After witnessing the ability of DCTs to rescue a number of clinical trials that were in jeopardy as a result of participants being unwilling or unable to safely travel […]
-
Study on Time Toxicity Reinforces Vlaue of Home-Based Trials
As part of the growing focus on patient-centric care, clinical trials need to provide the flexibility and convenience that allows trial participation to work around patient schedules to optimize quality of life. By Greg Austin The May 20 issue of The Journal of Clinical Oncology featured a timely, insightful study entitled “The […]
-
Decentralized Trials Are Better Understood, But 5 Misconceptions Persist
Executive Summary Even though decentralized clinical trials (DCTs) have existed for almost 20 years, many sponsors and CROs hesitated to employ them for a variety of reasons, including discomfort due to a lack of familiarity. But the COVID-19 pandemic changed that. Sponsors who would never have considered a DCT in […]
-
How Sponsors and CROs can Fully Benefit from the Permanent Shift to Decentralized Clinical Trials Brought About by the COVID-19 Pandemic
Executive Summary Evidence is mounting that hybrid and decentralized clinical trials are here to stay. What was once a nice-to-have is quickly transforming into a must-have. As reported in Clinical Trials Arena, roughly 1,300 clinical trials with a virtual and/or decentralized component will begin in 2022, representing a 93% increase […]
